Cargando…

Group-sequential analysis may allow for early trial termination: illustration by an intra-observer repeatability study

BACKGROUND: Group-sequential testing is widely used in pivotal therapeutic, but rarely in diagnostic research, although it may save studies, time, and costs. The purpose of this paper was to demonstrate a group-sequential analysis strategy in an intra-observer study on quantitative FDG-PET/CT measur...

Descripción completa

Detalles Bibliográficos
Autores principales: Gerke, Oke, Vilstrup, Mie H., Halekoh, Ulrich, Hildebrandt, Malene Grubbe, Høilund-Carlsen, Poul Flemming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5615083/
https://www.ncbi.nlm.nih.gov/pubmed/28952076
http://dx.doi.org/10.1186/s13550-017-0328-6
_version_ 1783266515416514560
author Gerke, Oke
Vilstrup, Mie H.
Halekoh, Ulrich
Hildebrandt, Malene Grubbe
Høilund-Carlsen, Poul Flemming
author_facet Gerke, Oke
Vilstrup, Mie H.
Halekoh, Ulrich
Hildebrandt, Malene Grubbe
Høilund-Carlsen, Poul Flemming
author_sort Gerke, Oke
collection PubMed
description BACKGROUND: Group-sequential testing is widely used in pivotal therapeutic, but rarely in diagnostic research, although it may save studies, time, and costs. The purpose of this paper was to demonstrate a group-sequential analysis strategy in an intra-observer study on quantitative FDG-PET/CT measurements, illuminating the possibility of early trial termination which implicates significant potential time and resource savings. METHODS: Primary lesion maximum standardised uptake value (SUVmax) was determined twice from preoperative FDG-PET/CTs in 45 ovarian cancer patients. Differences in SUVmax were assumed to be normally distributed, and sequential one-sided hypothesis tests on the population standard deviation of the differences against a hypothesised value of 1.5 were performed, employing an alpha spending function. The fixed-sample analysis (N = 45) was compared with the group-sequential analysis strategies comprising one (at N = 23), two (at N = 15, 30), or three interim analyses (at N = 11, 23, 34), respectively, which were defined post hoc. RESULTS: When performing interim analyses with one third and two thirds of patients, sufficient agreement could be concluded after the first interim analysis and the final analysis. Other partitions did not suggest early stopping after adjustment for multiple testing due to one influential outlier and our small sample size. CONCLUSIONS: Group-sequential testing may enable early stopping of a trial, allowing for potential time and resource savings. The testing strategy must, though, be defined at the planning stage, and sample sizes must be reasonably large at interim analysis to ensure robustness against single outliers. Group-sequential testing may have a place in accuracy and agreement studies. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13550-017-0328-6) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5615083
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-56150832017-10-11 Group-sequential analysis may allow for early trial termination: illustration by an intra-observer repeatability study Gerke, Oke Vilstrup, Mie H. Halekoh, Ulrich Hildebrandt, Malene Grubbe Høilund-Carlsen, Poul Flemming EJNMMI Res Short Communication BACKGROUND: Group-sequential testing is widely used in pivotal therapeutic, but rarely in diagnostic research, although it may save studies, time, and costs. The purpose of this paper was to demonstrate a group-sequential analysis strategy in an intra-observer study on quantitative FDG-PET/CT measurements, illuminating the possibility of early trial termination which implicates significant potential time and resource savings. METHODS: Primary lesion maximum standardised uptake value (SUVmax) was determined twice from preoperative FDG-PET/CTs in 45 ovarian cancer patients. Differences in SUVmax were assumed to be normally distributed, and sequential one-sided hypothesis tests on the population standard deviation of the differences against a hypothesised value of 1.5 were performed, employing an alpha spending function. The fixed-sample analysis (N = 45) was compared with the group-sequential analysis strategies comprising one (at N = 23), two (at N = 15, 30), or three interim analyses (at N = 11, 23, 34), respectively, which were defined post hoc. RESULTS: When performing interim analyses with one third and two thirds of patients, sufficient agreement could be concluded after the first interim analysis and the final analysis. Other partitions did not suggest early stopping after adjustment for multiple testing due to one influential outlier and our small sample size. CONCLUSIONS: Group-sequential testing may enable early stopping of a trial, allowing for potential time and resource savings. The testing strategy must, though, be defined at the planning stage, and sample sizes must be reasonably large at interim analysis to ensure robustness against single outliers. Group-sequential testing may have a place in accuracy and agreement studies. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13550-017-0328-6) contains supplementary material, which is available to authorized users. Springer Berlin Heidelberg 2017-09-26 /pmc/articles/PMC5615083/ /pubmed/28952076 http://dx.doi.org/10.1186/s13550-017-0328-6 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Short Communication
Gerke, Oke
Vilstrup, Mie H.
Halekoh, Ulrich
Hildebrandt, Malene Grubbe
Høilund-Carlsen, Poul Flemming
Group-sequential analysis may allow for early trial termination: illustration by an intra-observer repeatability study
title Group-sequential analysis may allow for early trial termination: illustration by an intra-observer repeatability study
title_full Group-sequential analysis may allow for early trial termination: illustration by an intra-observer repeatability study
title_fullStr Group-sequential analysis may allow for early trial termination: illustration by an intra-observer repeatability study
title_full_unstemmed Group-sequential analysis may allow for early trial termination: illustration by an intra-observer repeatability study
title_short Group-sequential analysis may allow for early trial termination: illustration by an intra-observer repeatability study
title_sort group-sequential analysis may allow for early trial termination: illustration by an intra-observer repeatability study
topic Short Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5615083/
https://www.ncbi.nlm.nih.gov/pubmed/28952076
http://dx.doi.org/10.1186/s13550-017-0328-6
work_keys_str_mv AT gerkeoke groupsequentialanalysismayallowforearlytrialterminationillustrationbyanintraobserverrepeatabilitystudy
AT vilstrupmieh groupsequentialanalysismayallowforearlytrialterminationillustrationbyanintraobserverrepeatabilitystudy
AT halekohulrich groupsequentialanalysismayallowforearlytrialterminationillustrationbyanintraobserverrepeatabilitystudy
AT hildebrandtmalenegrubbe groupsequentialanalysismayallowforearlytrialterminationillustrationbyanintraobserverrepeatabilitystudy
AT høilundcarlsenpoulflemming groupsequentialanalysismayallowforearlytrialterminationillustrationbyanintraobserverrepeatabilitystudy